Walvax Pharmaceutical (002907.SZ) released its first three quarters performance, with net profit attributable to the parent company of 101 million yuan, a year-on-year increase of 39.67%.

Zhitong Finance APP News, Huasen Pharmaceutical (002907.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 649 million yuan, a year-on-year increase of 3.70%; net profit attributable to shareholders of the listed company was 101 million yuan, a year-on-year increase of 39.67%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 83.6121 million yuan, a year-on-year increase of 60.17%; basic earnings per share were 0.2423 yuan.